John Castle
Chief Tech/Sci/R&D Officer bei MONTE ROSA THERAPEUTICS, INC.
Vermögen: - $ am 31.03.2024
Profil
John Castle is currently the Chief Data & Information Officer at Monte Rosa Therapeutics, Inc. He previously worked as an Associate Director at Rosetta Inpharmatics LLC.
From 2009 to 2014, he was the Director-Computational Medicine at BioNTech SE.
He also served as a Director at Encompass Northwest and Cadence Biomedical, Inc. From 2014 to 2020, he held the position of Associate Vice President-Translational Medicine at Agenus, Inc. In 2017, he briefly served as the Chief Scientific Officer at Achilles Therapeutics UK Ltd.
Dr. Castle holds a doctorate degree from the University of Washington, an undergraduate degree from Rice University, and undergraduate and doctorate degrees from the Massachusetts Institute of Technology.
He also has an MBA from Harvard Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.01.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von John Castle
| Unternehmen | Position | Beginn |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von John Castle
| Unternehmen | Position | Ende |
|---|---|---|
| AGENUS INC. | Corporate Officer/Principal | 01.04.2020 |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | 01.01.2018 |
| BIONTECH SE | Corporate Officer/Principal | 01.11.2014 |
Rosetta Inpharmatics LLC
 Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Cadence Biomedical, Inc.
 Cadence Biomedical, Inc. Medical DistributorsDistribution Services Cadence Biomedical, Inc. provides medical devices for mobility impairments. Its product kickstart is a neurorehabilitation technology used to train walking skills and enable more independent, safe walking for patients following a stroke or other neurological condition. The company was founded by Jason A. Schoen and Brian Glaister in August 2007 and is headquartered in Seattle, WA. | Director/Board Member | - |
Ausbildung von John Castle
| University of Washington | Doctorate Degree |
| Rice University | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AGENUS INC. | Health Technology |
| BIONTECH SE | Health Technology |
| MONTE ROSA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Rosetta Inpharmatics LLC
Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Health Technology |
Encompass Northwest
 Encompass Northwest Services to the Health IndustryHealth Services Encompass Northwest is a non-profit organization, which provides education and pediatric therapy programs to typically-developing children and those with delays and/or disabilities. It offers early learning, parent education, parent-child interaction therapy, and family enrichment programs. The company was founded in 1966 and is headquartered in North Bend, WA. | Health Services |
Cadence Biomedical, Inc.
Cadence Biomedical, Inc. Medical DistributorsDistribution Services Cadence Biomedical, Inc. provides medical devices for mobility impairments. Its product kickstart is a neurorehabilitation technology used to train walking skills and enable more independent, safe walking for patients following a stroke or other neurological condition. The company was founded by Jason A. Schoen and Brian Glaister in August 2007 and is headquartered in Seattle, WA. | Distribution Services |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Health Technology |
